Evidence map›Paper›PMID 33810314›Full record

ReviewInternational journal of molecular sciences2021

Role of TRPA1 in Tissue Damage and Kidney Disease.

Chung-Kuan Wu, Ji-Fan Lin, Tzong-Shyuan Lee, Yu Ru Kou, Der-Cherng Tarng

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. TRPA1-Related Diseases and Applications of Nanotherapy.International journal of molecular sciences · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Research Progress on TRPA1 in Diseases.The Journal of membrane biology · 2023
    Review
  7. Article
  8. TRPA1 as Target in Myocardial Infarction.International journal of molecular sciences · 2023
    Article
  9. Inflammation-the role of TRPA1 channel.Frontiers in physiology · 2023
    Review
  10. Interleukin 1 beta-induced calcium signaling via TRPA1 channels promotes mitogen-activated protein kinase-dependent mesangial cell proliferation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Chung-Kuan WuDivision of Nephrology, Department of Internal Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei 111, Taiwan.ORCID 0000-0003-4446-0167
Ji-Fan LinPrecision Medicine Center, Department of Research, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei 111, Taiwan.ORCID 0000-0003-3953-4766
Tzong-Shyuan LeeDepartment of Physiology, College of Medicine, National Taiwan University, Taipei 100, Taiwan.ORCID 0000-0002-9593-4062
Yu Ru KouDepartment of Institue of Physiology, School of Medicine, National Yang-Ming University, Taipei 112, Taiwan.ORCID 0000-0002-4681-9009
Der-Cherng TarngDepartment of Institue of Physiology, School of Medicine, National Yang-Ming University, Taipei 112, Taiwan.ORCID 0000-0001-9017-2081
National Yang Ming Chiao Tung University · TWFu Jen Catholic University · TWNational Taiwan University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TRPA1, a nonselective cation channel, is expressed in sensory afferent that innervates peripheral targets. Neuronal TRPA1 can promote tissue repair, remove harmful stimuli and induce protective responses via the release of neuropeptides after the activation of the channel by chemical, exogenous, or endogenous irritants in the injured tissue. However, chronic inflammation after repeated noxious stimuli may result in the development of several diseases. In addition to sensory neurons, TRPA1, activated by inflammatory agents from some non-neuronal cells in the injured area or disease, might promote or protect disease progression. Therefore, TRPA1 works as a molecular sentinel of tissue damage or as an inflammation gatekeeper. Most kidney damage cases are associated with inflammation. In this review, we summarised the role of TRPA1 in neurogenic or non-neurogenic inflammation and in kidney disease, especially the non-neuronal TRPA1. In in vivo animal studies, TRPA1 prevented sepsis-induced or Ang-II-induced and ischemia-reperfusion renal injury by maintaining mitochondrial haemostasis or via the downregulation of macrophage-mediated inflammation, respectively. Renal tubular epithelial TRPA1 acts as an oxidative stress sensor to mediate hypoxia-reoxygenation injury in vitro and ischaemia-reperfusion-induced kidney injury in vivo through MAPKs/NF-kB signalling. Acute kidney injury (AKI) patients with high renal tubular TRPA1 expression had low complete renal function recovery. In renal disease, TPRA1 plays different roles in different cell types accordingly. These findings depict the important role of TRPA1 and warrant further investigation.

Indexed as

AnimalsHumansInflammationKidney DiseasesNeuronsSignal TransductionTRPA1 Cation ChannelTRPA1 Cation Channelinflammationkidney diseasetissue damageTRPA1

Identifiers

PMID33810314
PMCPMC8036557
OpenAlexW3141153214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.